Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00828555

Enrollment

3988

Registered

2009-01-26

Start date

2008-11-30

Completion date

2012-02-29

Last updated

2012-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza Vaccine, Papillomavirus Infection, Pertussis

Keywords

HPV vaccine, Tdap vaccine

Brief summary

PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases. SPECIFIC AIMS 1. Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel & office staff on their: * Attitudes towards vaccination of women against preventable diseases * Perceived barriers to implementing a program to vaccinate women in their offices * Ideas on how to overcome barriers to successful program implementation * Current vaccination practices and office-specific administrative processes 2. Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis 3. Determine the effectiveness of the vaccination program based on * Pre- and post-program vaccination rates * Program satisfaction amongst Ob/Gyn providers and office staff * Willingness to continue and possibly extend the program to additional vaccines 4. Quantify the level of support and resources needed to develop and implement the vaccination program

Interventions

OTHERVaccination Program

Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis

Eligibility

Sex/Gender

FEMALE

Age

12 Years to 26 Years

Healthy volunteers

Yes

Inclusion criteria

* 4-5 community Ob/Gyn practices

Design outcomes

Primary

Measure	Time frame
Implementation and measurement of a health services intervention in community or private Ob/Gyn practices to improve the delivery of standard clinical care to vaccinate women against human papillomavirus, influenza, & pertussis.	Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026